Clinical trial

Estriol Treatment in Multiple Sclerosis (MS): Effect on Cognition

NCT01466114

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2011-10-01

PhasePHASE2

Study timeline

Study start (unknown)2011-10-01Date precision: month

Registry last updated2019-11-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Relapsing-remitting Multiple Sclerosisunresolved

Secondary-progressive Multiple Sclerosisunresolved

Primary-progressive Multiple Sclerosisunresolved

Interventions

estriolDRUG · verified · RxNorm: estriol

NorethindroneDRUG · verified · RxNorm: norethindrone

Progestin PlaceboOTHER

Sponsors & collaborators

University of California, Los Angeleslead sponsor

Mapped research locations

Los AngelesCalifornia, United States1 PhiladelphiaPennsylvania, United States1 AuroraColorado, United States1 AlbuquerqueNew Mexico, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01466114 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.